欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
ES/V/0233/001
药品名称
REVERSE
活性成分
atipamezole hydrochloride 5.0 mg/ml
剂型
Solution for injection
上市许可持有人
Fatro S.p.A
参考成员国 - 产品名称
Spain (ES)
REVERSE 5 MG/ML SOLUCIÓN INYECTABLE PARA PERROS Y GATOS
互认成员国 - 产品名称
Portugal (PT)
Italy (IT)
许可日期
2016/01/27
最近更新日期
2023/11/24
药物ATC编码
QV03AB90 atipamezole
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
Generic - art 13.2 Dir 2001/82/EC
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final Product Information
|
spc_labelling_pl_qrd_vers_9_proposed_clean
Date of last change:2023/11/24
Final SPC
|
common-spc-day-90
Date of last change:2020/10/30
Final Labelling
|
common-labelling-proposed-clean-day-90
Date of last change:2020/10/30
Final PL
|
common-pl-clean-day-90
Date of last change:2020/10/30
PAR
|
PuAR_REVERSE
Date of last change:2016/11/30
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase